Liminal BioSciences Inc.(LMNL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community

At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.

Close

LMNL Liminal BioSciences Inc.

Closed 11-03 16:00:00 EDT

8.50

+0.00

0.00%

High8.50	Low8.50	Vol0.00
Open8.50	D1 Closing8.50	Amplitude0.00%
Mkt Cap27.62M	Tradable Cap10.69M	Total Shares3.25M
T/O0.00	T/O Rate0.00%	Tradable Shares1.26M
P/B--	ROE--	EPS0.00
52wk High--	52wk Low--	P/E--
Dividend--	Div.Yield--	ROA--

{"stockData":{"symbol":"LMNL","market":"US","secType":"STK","nameCN":"Liminal BioSciences Inc.","latestPrice":8.5,"timestamp":1699041600000,"preClose":8.5,"halted":0,"volume":0,"delay":0,"floatShares":1257210,"shares":3249534,"eps":0.32017,"marketStatus":"Closed","change":0,"latestTime":"11-03 16:00:00 EDT","open":8.5,"high":8.5,"low":8.5,"amount":0,"amplitude":0,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.32017,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Market Trading","tradingStatus":1,"beginTime":1732525200000},"marketStatusCode":5,"adr":0,"exchange":"NASDAQ","adjPreClose":8.5,"volumeRatio":0},"requestUrl":"/m/hq/s/LMNL","defaultTab":"news","newsList":[{"id":"2370795542","title":"LIMINAL BIOSCIENCES ANNOUNCES COMPLETION OF THE PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LP","url":"https://stock-news.laohu8.com/highlight/detail?id=2370795542","media":"CNW Group","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2370795542?lang=en_us&edition=fundamental","pubTime":"2023-09-26 20:00","pubTimestamp":1695729600,"startTime":"0","endTime":"0","summary":"LAVAL, QC and CAMBRIDGE, England, Sept. 26, 2023 /CNW/ - Liminal BioSciences Inc.  is pleased to announce that the transaction contemplated by the previously announced statutory plan of arrangement under the provisions of the Canada Business Corporations Act involving the Corporation and Structured Alpha LP , a limited partnership managed by its general partner, Thomvest Asset Management Ltd., was completed earlier today . Pursuant to the Arrangement, SALP acquired all of the issued and outstanding common shares of Liminal BioSciences  not currently owned by SALP or its affiliates and associates  at a price of US$8.50 per Share, payable in cash .","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/ZYDVrWMz59tpMuwBmVbpUA--~B/aD0xMTY7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/cnwgroup.com/d64545f389740b8410ce287b2405c50a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/ZYDVrWMz59tpMuwBmVbpUA--~B/aD0xMTY7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/cnwgroup.com/d64545f389740b8410ce287b2405c50a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/liminal-biosciences-announces-completion-plan-120000853.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["DRS","BK4023","LMNL","BK4551","BK4187","PLAN","BK4139"],"gpt_icon":0},{"id":"2368133665","title":"Liminal BioSciences gets final order for the Structured Alpha takeover","url":"https://stock-news.laohu8.com/highlight/detail?id=2368133665","media":"seekingalpha","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2368133665?lang=en_us&edition=fundamental","pubTime":"2023-09-20 05:24","pubTimestamp":1695158668,"startTime":"0","endTime":"0","summary":"Liminal BioSciences  said Tuesday it has received the Ontario Superior Court of Justice's final order for Structured Alpha LP to acquire all outstanding shares of the company it does not already own for US$8.50 per share in cash. Structured Alpha LP is a limited partnership managed by its general partner, Thomvest Asset Management Ltd. The transaction is expected to be completed on or about September 26th, 2023.  Press Release.   More on Liminal BioSciences  Seeking Alpha’s Quant Rating on Liminal BioSciences Financial information for Liminal BioSciences Liminal BioSciences shareholders to vote on takeover deal Sept. 15 Liminal to go private in buyout deal with Structured Alpha","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://seekingalpha.com/news/4013458-liminal-biosciences-gets-final-order-for-the-structured-alpha-takeover","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"seekingalpha","symbols":["BK4139","LMNL"],"gpt_icon":0},{"id":"2368363180","title":"Press Release: LIMINAL BIOSCIENCES RECEIVES FINAL COURT ORDER FOR PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LP","url":"https://stock-news.laohu8.com/highlight/detail?id=2368363180","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2368363180?lang=en_us&edition=fundamental","pubTime":"2023-09-20 04:22","pubTimestamp":1695154920,"startTime":"0","endTime":"0","summary":"LAVAL, QC and CAMBRIDGE, England, Sept. 19, 2023 /CNW/ - Liminal BioSciences Inc.  , is pleased to announce that it received the final order of the Ontario Superior Court of Justice  approving the previously-announced plan of arrangement under section 192 of the Canada Business Corporations Act  pursuant to which Structured Alpha LP , a limited partnership managed by its general partner, Thomvest Asset Management Ltd., will acquire all of the issued and outstanding common shares of Liminal BioSciences  not currently owned by SALP or its affiliates and associates at a price of US$8.50 per Share, payable in cash .The Arrangement was previously approved by the Company's shareholders at the special meeting of the Company held on September 15, 2023.Liminal BioSciences has active business operations in Canada and the United Kingdom.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","LMNL","BK4024","FOR","PLAN","BK4139","BK4551"],"gpt_icon":0},{"id":"2367648044","title":"Press Release: LIMINAL BIOSCIENCES SHAREHOLDERS APPROVE PLAN OF ARRANGEMENT WITH STRUCTURED ALPHA LP","url":"https://stock-news.laohu8.com/highlight/detail?id=2367648044","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2367648044?lang=en_us&edition=fundamental","pubTime":"2023-09-15 23:29","pubTimestamp":1694791740,"startTime":"0","endTime":"0","summary":"LAVAL, QC and CAMBRIDGE, England, Sept. 15, 2023 /PRNewswire/ - Liminal BioSciences Inc.  , is pleased to announce that its shareholders have approved the previously-announced plan of arrangement under section 192 of the Canada Business Corporations Act  pursuant to which Structured Alpha LP , a limited partnership managed by its general partner, Thomvest Asset Management Ltd., will acquire all of the issued and outstanding common shares of Liminal BioSciences  not currently owned by SALP or its affiliates and associates at a price of US$8.50 per Share, payable in cash . Further details regarding the Arrangement are described in the management information circular dated August 16, 2023  mailed to Liminal BioSciences shareholders in connection with the Arrangement, as well as in the supplement to the Circular dated September 12, 2023, each of which is available under the Company's profile on SEDAR+ at www.sedarplus.ca and on EDGAR at www.sec.gov.Liminal BioSciences is a development stag","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4023","LMNL","BK4139","PLAN","BK4551"],"gpt_icon":0}],"profile":{"websiteUrl":"http://www.liminalbiosciences.com","stockEarnings":[{"period":"1week","weight":0},{"period":"1month","weight":0},{"period":"3month","weight":0},{"period":"6month","weight":0},{"period":"1year","weight":0},{"period":"ytd","weight":0}],"compareEarnings":[{"period":"1week","weight":0.0005},{"period":"1month","weight":0.0177},{"period":"3month","weight":0.0561},{"period":"6month","weight":0.1213},{"period":"1year","weight":0.3047},{"period":"ytd","weight":0.249}],"compareStock":{"symbol":"SPY","name":"SPDR S&P 500 ETF Trust"},"description":"Liminal BioSciences Inc., a development stage biopharmaceutical company, focuses on the development of novel small molecule drug therapeutics for inflammatory, fibrotic, and metabolic diseases in Canada and the United Kingdom. The company is developing LMNL6511, a selective antagonist for the G-protein coupled receptor 84, is expected to commence a Phase 1 clinical trial. It is also developing potential OXER1 antagonists and GPR40 agonists, which are in preclinical stage. The company was formerly known as Prometic Life Sciences Inc. and changed its name to Liminal BioSciences Inc. in October 2019. Liminal BioSciences Inc. was incorporated in 1994 and is headquartered in Laval, Canada.","yearOnYearQuotes":[{"month":1,"riseRate":0.75,"avgChangeRate":0.10416},{"month":2,"riseRate":0.5,"avgChangeRate":0.047116},{"month":3,"riseRate":0.25,"avgChangeRate":-0.134873},{"month":4,"riseRate":0.75,"avgChangeRate":0.246402},{"month":5,"riseRate":0.25,"avgChangeRate":-0.046694},{"month":6,"riseRate":0.25,"avgChangeRate":-0.035706},{"month":7,"riseRate":0.5,"avgChangeRate":0.102083},{"month":8,"riseRate":0.5,"avgChangeRate":-0.057325},{"month":9,"riseRate":0.25,"avgChangeRate":-0.067063},{"month":10,"riseRate":0.333333,"avgChangeRate":-0.194846},{"month":11,"riseRate":0,"avgChangeRate":-0.190917},{"month":12,"riseRate":0.5,"avgChangeRate":0.026477}],"exchange":"NASDAQ","name":"Liminal BioSciences Inc.","nameEN":"Liminal BioSciences Inc."},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"deviceId":"web-server-community-laohu8-v3","version":"4.29.2","shortVersion":"4.29.2","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"Liminal BioSciences Inc.(LMNL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","description":"Find the latest Liminal BioSciences Inc.(LMNL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","keywords":"Liminal BioSciences Inc.,LMNL,Liminal BioSciences Inc.股票,Liminal BioSciences Inc.股票老虎,Liminal BioSciences Inc.股票老虎国际,Liminal BioSciences Inc.行情,Liminal BioSciences Inc.股票行情,Liminal BioSciences Inc.股价,Liminal BioSciences Inc.股市,Liminal BioSciences Inc.股票价格,Liminal BioSciences Inc.股票交易,Liminal BioSciences Inc.股票购买,Liminal BioSciences Inc.股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"Liminal BioSciences Inc.(LMNL),Stock Price, Discussion, News, Quote & History - To The Moon - Tiger Brokers Online Investing Community","og_description":"Find the latest Liminal BioSciences Inc.(LMNL) stock quote, history, news, and investing ideas from To The Moon - Tiger Brokers Online Investing Community to stay on top of the markets.","og_image":"https://community-static.tradeup.com/news/9b6dafd60190235ae8e2c95f52c583a0"}}}

Introduction